[Editorial] Balancing the benefits and risks of choice
Last week, Public Health England (PHE) published new guidance: Opting out of the NHS population screening programmes. This guidance is a tacit acknowledgment that screening in the UK faces serious challenges in how it is perceived and used by the public. It signals that there are limitations to the evidence, the idea of prevention, and cost. It suggests a major shift in the public’s perception of screening in society, as well as raising issues of patient choice and informed consent.